Yan L - Search Results

1

The Prevalence and Long-Term Outcomes of Extreme Right versus Extreme Left Ventricular Hypertrophic Cardiomyopathy.

Guo X, Fan C, Wang H, Zhao S, Duan F, Wang Z, Yan L, Yang Y, An S, Li Y. Guo X, et al. Among authors: yan l. Cardiology. 2016;133(1):35-43. doi: 10.1159/000439345. Epub 2015 Sep 29. Cardiology. 2016. PMID: 26414322

2

Two hundred eight patients with apical hypertrophic cardiomyopathy in china: clinical feature, prognosis, and comparison of pure and mixed forms.

Yan L, Wang Z, Xu Z, Li Y, Tao Y, Fan C. Yan L, et al. Clin Cardiol. 2012 Feb;35(2):101-6. doi: 10.1002/clc.20995. Epub 2011 Nov 28. Clin Cardiol. 2012. PMID: 22125122 Free PMC article.

3

[Clinical features and long-term outcome comparison of patients with midventricular obstructive hypertrophic cardiomyopathy and apical hypertrophic cardiomyopathy].

An S, Cai C, Duan F, Yang Y, Guo X, Liu Y, Liu Y, Yan L, Xu Z, Zhao S, Hua W, Fan C, Li Y. An S, et al. Among authors: yan l. Zhonghua Xin Xue Guan Bing Za Zhi. 2015 Oct;43(10):874-8. Zhonghua Xin Xue Guan Bing Za Zhi. 2015. PMID: 26652989 Chinese.

4

Comparison of Long-Term Outcome between Apical and Asymmetric Septal Hypertrophic Cardiomyopathy.

An S, Fan C, Yan L, Cai C, Yang Y, Zhai S, Zhao S, Liu Y, Duan F, Wang Z, Li Y. An S, et al. Among authors: yan l. Cardiology. 2017;136(2):108-114. doi: 10.1159/000448239. Epub 2016 Sep 6. Cardiology. 2017. PMID: 27595481

5

Comparison of the prevalence, clinical features, and long-term outcomes of midventricular hypertrophy vs apical phenotype in patients with hypertrophic cardiomyopathy.

Cai C, Duan FJ, Yang YJ, Guo XY, Liu YL, Liu YQ, Yan LR, Xu ZM, Zhao SH, Hua W, Li YS, Fan CM. Cai C, et al. Can J Cardiol. 2014 Apr;30(4):441-7. doi: 10.1016/j.cjca.2013.10.005. Epub 2013 Oct 9. Can J Cardiol. 2014. PMID: 24468417

6

Clinical characteristics and prognosis of 60 patients with midventricular obstructive hypertrophic cardiomyopathy.

Yan LR, Zhao SH, Wang HY, Duan FJ, Wang ZM, Yang YJ, Guo XY, Cai C, Xu ZM, Li YS, Fan CM. Yan LR, et al. J Cardiovasc Med (Hagerstown). 2015 Nov;16(11):751-60. doi: 10.2459/JCM.0000000000000163. J Cardiovasc Med (Hagerstown). 2015. PMID: 25022933

7

Clinical Outcomes of Myocardial Bridging versus No Myocardial Bridging in Patients with Apical Hypertrophic Cardiomyopathy.

Zhai SS, Fan CM, An SY, Hang F, Yang YJ, Yan LR, Guo XY, Li YS. Zhai SS, et al. Cardiology. 2018;139(3):161-168. doi: 10.1159/000486276. Epub 2018 Jan 31. Cardiology. 2018. PMID: 29393099

8

[Clinical features and prognosis of 188 Chinese patients with apical hypertrophic cardiomyopathy].

Tao YK, Yan LR, Li YS, Xu ZM, Zhang GQ, Zu LM, DU HY, Fan CM. Tao YK, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Feb;39(2):106-9. Zhonghua Xin Xue Guan Bing Za Zhi. 2011. PMID: 21426741 Chinese.

9

[Update on apical hypertrophic cardiomyopathy].

Yan LR, Fan CM. Yan LR, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Oct;39(10):970-2. Zhonghua Xin Xue Guan Bing Za Zhi. 2011. PMID: 22321285 Chinese. No abstract available.

10

Efficacy and safety of aranidipine enteric-coated tablets compared with amlodipine in Chinese patients with mild to moderate essential hypertension: a multicenter, randomized, double-blind, parallel-controlled clinical trial.

Yan LR, Li YS, Chen GL, Wang L, Pang HM, Wu SY, Yu J, Li HM, Lin YZ, Zhao RP, Fan CM. Yan LR, et al. J Cardiovasc Pharmacol. 2012 Jul;60(1):8-14. doi: 10.1097/FJC.0b013e318254a566. J Cardiovasc Pharmacol. 2012. PMID: 22441301 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,689 results

Search Page

Filters